2nd Quarter - Report

AMEDISYS, INC. for AMEDISYS, INC.

Firm
Client
Income
—
Expenses
$310,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to Centers for Medicare & Medicaid Services policy and issues impacting Medicare/Medicare Advantage and related issues for home health and hospice; issues related to COVID-19 and related legislation (H.R. 6201, Families First Coronavirus Response Act & H.R. 748 Coronavirus Aid, Relief, and Economic Security Act (CARES Act)) and related regulatory action including CMS-1744-IFC- Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency ; CMMI Home Health Value Based Purchasing Demonstration; CMMI Value Based Insurance Design; H.R. 6800 (Health and Economic Recovery Omnibus Emergency Solutions Act); H.R. 266 (Paycheck Protection Program and Health Care Enhancement Act).

LobbyistCovered position, as disclosed
DAVE KEMMERLY —
SCOTT M. LEVY —

Contacted: SENATE; Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: H.R. 266 (116th), H.R. 6201 (116th), H.R. 6800 (116th), H.R. 748 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.